Your browser doesn't support javascript.
loading
Analysis on Reimbursement Limits of National Basic Medical Insurance Drug List 2017 / 中国卫生经济
Chinese Health Economics ; (12): 48-50, 2018.
Artigo em Chinês | WPRIM | ID: wpr-703431
ABSTRACT

Objective:

Analyzing reimbursement limits of National Basic Medical Insurance Drug List 2017.

Methods:

The kinds of reimbursement limits and characters of relative drugs inquantities,categories and indications were concluded through methods of induction and correlation.

Results:

903 drugs were limited in National Basic Medical Insurance Drug List 2017,involving categories of insurance,serviceable range of pooling funds,second-line use and indications.

Conclusion:

The reimbursement limits were normative,ensuring rational drug use and efficiency of medical insurance funds.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Health Economics Ano de publicação: 2018 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Health Economics Ano de publicação: 2018 Tipo de documento: Artigo